Tumor malignancy defined by aberrant glycosylation and sphingo(glyco)lipid metabolism - PubMed (original) (raw)
Review
. 1996 Dec 1;56(23):5309-18.
Affiliations
- PMID: 8968075
Review
Tumor malignancy defined by aberrant glycosylation and sphingo(glyco)lipid metabolism
S Hakomori. Cancer Res. 1996.
Abstract
Aberrant glycosylation expressed in glycosphingolipids and glycoproteins in tumor cells has been implicated as an essential mechanism in defining stage, direction, and fate of tumor progression. This general concept is supported by results from three lines of study: (a) Numerous clinicopathological studies have shown a clear correlation between aberrant glycosylation status of primary tumor and invasive/metastatic potential of human cancer as reflected by 5- or 10-year survival rates of patients. (b) Carbohydrates expressed in tumor cells are either adhesion molecules per se or modulate adhesion receptor function. Some are directly involved in cell adhesion. They are recognized by selectins or other carbohydrate-binding proteins or by complementary carbohydrates (through carbohydrate-carbohydrate interaction). N- or O-glycosylation of functionally important membrane components may alter tumor cell adhesion or motility in a direction that either promotes or inhibits invasion and metastasis. Examples of such receptors are E-cadherin, integrins, immunoglobulin family receptors (e.g., CD44), and lysosome-associated membrane protein. (c) Gangliosides and sphingolipids modulate transmembrane signaling essential for tumor cell growth, invasion, and metastasis. The transducer molecules susceptible to gangliosides and sphingolipids include integrin receptors, tyrosine kinase-linked growth factor receptors, protein kinase C, and G-protein-linked receptor affecting protein kinase A. Some glycosphingolipids (e.g., Gb3Cer, Le(y), ceramide, and sphingosine induce tumor cell differentiation and subsequent apoptosis. Shedded gangliosides may block immunogenicity of tumor cells, providing conditions favorable for "escape" from immunological suppression of tumor growth by the host. Various reagents that block carbohydrate-mediated tumor cell adhesion or block glycosylation processing have been shown to inhibit tumor cell metastasis. This provides the basis for further development of "anti-adhesion therapy." Ganglioside analogues and sphingolipid analogues that inhibit protein kinase C and receptor-associated tyrosine kinase have been applied for inhibition of metastasis. A crucial mechanism for inhibition of metastasis by these reagents may involve blocking of transmembrane signaling for expression of P- and E-selectin. This provides the basis for development of "ortho-signaling therapy."
Similar articles
- Disialosyl galactosylgloboside as an adhesion molecule expressed on renal cell carcinoma and its relationship to metastatic potential.
Satoh M, Handa K, Saito S, Tokuyama S, Ito A, Miyao N, Orikasa S, Hakomori S. Satoh M, et al. Cancer Res. 1996 Apr 15;56(8):1932-8. Cancer Res. 1996. PMID: 8620516 - Metastasis tumor antigen family proteins during breast cancer progression and metastasis in a reliable mouse model for human breast cancer.
Zhang H, Stephens LC, Kumar R. Zhang H, et al. Clin Cancer Res. 2006 Mar 1;12(5):1479-86. doi: 10.1158/1078-0432.CCR-05-1519. Clin Cancer Res. 2006. PMID: 16533771 - B lymphocyte binding to E- and P-selectins is mediated through the de novo expression of carbohydrates on in vitro and in vivo activated human B cells.
Postigo AA, Marazuela M, Sánchez-Madrid F, de Landázuri MO. Postigo AA, et al. J Clin Invest. 1994 Oct;94(4):1585-96. doi: 10.1172/JCI117500. J Clin Invest. 1994. PMID: 7523454 Free PMC article. - Adhesion molecules in tumor metastasis.
Zetter BR. Zetter BR. Semin Cancer Biol. 1993 Aug;4(4):219-29. Semin Cancer Biol. 1993. PMID: 8400144 Review.
Cited by
- A shift from N-glycolyl- to N-acetyl-sialic acid in the GM3 ganglioside impairs tumor development in mouse lymphocytic leukemia cells.
Casadesús AV, Fernández-Marrero Y, Clavell M, Gómez JA, Hernández T, Moreno E, López-Requena A. Casadesús AV, et al. Glycoconj J. 2013 Oct;30(7):687-99. doi: 10.1007/s10719-013-9473-y. Epub 2013 Apr 2. Glycoconj J. 2013. PMID: 23547010 - Sialylation of E-cadherin does not change the spontaneous or ET-18-OMe-mediated aggregation of MCF-7 human breast cancer cells.
Steelant WF, Recchi MA, Noë VT, Boilly-Marer Y, Bruyneel EA, Verbert A, Mareel MM, Delannoy P. Steelant WF, et al. Clin Exp Metastasis. 1999 May;17(3):245-53. doi: 10.1023/a:1006639804430. Clin Exp Metastasis. 1999. PMID: 10432010 - Inhibition of glycolipid shedding rescues recognition of a CD1+ T cell lymphoma by natural killer T (NKT) cells.
Sriram V, Cho S, Li P, O'Donnell PW, Dunn C, Hayakawa K, Blum JS, Brutkiewicz RR. Sriram V, et al. Proc Natl Acad Sci U S A. 2002 Jun 11;99(12):8197-202. doi: 10.1073/pnas.122636199. Proc Natl Acad Sci U S A. 2002. PMID: 12060764 Free PMC article. - Synthesis of reference standards to enable single cell metabolomic studies of tetramethylrhodamine-labeled ganglioside GM1.
Larsson EA, Olsson U, Whitmore CD, Martins R, Tettamanti G, Schnaar RL, Dovichi NJ, Palcic MM, Hindsgaul O. Larsson EA, et al. Carbohydr Res. 2007 Feb 26;342(3-4):482-9. doi: 10.1016/j.carres.2006.10.002. Epub 2006 Oct 7. Carbohydr Res. 2007. PMID: 17069778 Free PMC article. - Glycosylation defining cancer cell motility and invasiveness.
Ono M, Hakomori S. Ono M, et al. Glycoconj J. 2004;20(1):71-8. doi: 10.1023/B:GLYC.0000018019.22070.7d. Glycoconj J. 2004. PMID: 14993838 Review. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Miscellaneous